Showing results (621-630 of 632) with videos related to
Sort By:
Pageof 64
Journal of Medicinal Chemistry|December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P1 Receptor ModulatorMichael G Yang, Zili Xiao, T G Murali Dhar, et al.ACS Medicinal Chemistry Letters|May 31, 2021
Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and PsoriasisQingjie Liu, Hai-Yun Xiao, Douglas G Batt, et al.Nature Immunology|May 22, 2026
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccinesKautilya K Jena, Pengxiang Qu, Lauren Baracco, et al.Journal of Crohn'S & Colitis|October 30, 2015
Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease RegistryHai Yun Shi, Francis K L Chan, Wai Keung Leung, et al.Therapeutic Advances in Gastroenterology|July 2, 2016
Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registryHai Yun Shi, Francis K L Chan, Wai Keung Leung, et al.Journal of Medicinal Chemistry|April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel DiseaseHeidi L Perez, Sunita Dewnani, Steven A Spronk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survivalHai-Yun Wang, Bing-Yu Sun, Zhi-Hua Zhu, et al.Inflammatory Bowel Diseases|July 15, 2016
Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong KongSiew C Ng, Wai Keung Leung, Hai Yun Shi, et al.Journal of Medicinal Chemistry|October 12, 2016
Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug DesignHai-Yun Xiao, Scott H Watterson, Charles M Langevine, et al.World Journal of Psychiatry|November 20, 2024
Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophreniaBao-Yan Xu, Kun Jin, Hai-Shan Wu, et al.Pageof 64